Dr. Mark A. Moyad, Director of Preventative and Alternative Medicine at the University of Michigan Medical Center has published a number of articles and studies exploring the health and medicine significance of one of the most studied organisms in history; Saccharomyces cerevisiae.
In his two part article in the journal Urologic NursingMoyad touches on the unique nature and potential clinical significance of S. cerevisiae.Known for its uses in the preparation of foods and beverages throughout recorded history, this adaptable and unicellular organism is receiving more attention in the domains of preventative medicine and longevity research; due in part to its highly similar cellular structure when compared to human cells.Clinicians familiar with the scientific history of vitamins and micronutrients know that many enzymes and vitamins were first discovered in S. cerevisiae; they are rich, for instance, in most B-complex vitamins.
Moyad points out several “encouraging” research discoveries and endeavors utilizing S. cerevisiae.These include, among others…
S. cerevisiae continues to be used in numerous animal and human studies without significant adverse effects.
It appears to serve multiple functions, from protein supplementation, to energy boosting and immune enhancement.
S. cerevisiae is being utilized extensively in longevity studies such as Caloric Restriction research and genetic activation.
The year following publication of Moyad’s two part article, he was the lead writer of clinical research published in the journal Advances in Therapy on the reduction of Allergic Rhinitis (AR) and supplementation with S. cerevisiae.In this 12-week randomized, double-blind, placebo-controlled clinical trial participants receiving daily supplementation with 500 mg of modified S. cerevisiae showed a significant reduction in AR symptoms and nasal congestion.Moyad, et al also published the findings of two separate clinical trials reporting statistically significant reductions in incidence (2008) and duration of (2008 & 2010) of cold/flu symptoms in vaccinated (2008) and nonvaccinated individuals (2010).Based on these promising findings as well as outside studies, Moyad, et al, encourage further research into the clinical significance and medical understanding of S. cerevisiae.
Studies & References
Moyad, Mark A., Urol Nurs, Vol 27 & 26 (2007, 2008)
Moyad, M.A., et al, Urol Nurs, 28:50-5 (2008)
__________,Adv Ther, 26(8): 795-804 (2009)
__________, J Altern Complement Med 16(2):213-8 (2010)
